Crdentia Selected by High Rock Raceway to Provide Healthcare Staffin... ( DALLAS Sept. 6 /- Crdentia Corp. ...)

Crdentia Selected by High Rock Raceway to Provide Healthcare Staffing Services

Date:9/6/2007

DALLAS, Sept. 6 /PRNewswire-FirstCall/ -- Crdentia Corp. (OTC Bulletin Board: CRDT), a leading U.S. provider of healthcare staffing services, today announced that it has been awarded an exclusive healthcare staffing contract by High Rock Raceway in Spencer, North Carolina. High Rock Raceway is a new development project that includes a two-and-a-quarter-mile road track, 120 track-side condominiums and nearby single-family lots.

High Rock Raceway has partnered with Crdentia to ensure the healthcare program developed for this unique mixed-use property will provide guests, owners, and participants with the highest level of medical care and safety. Under terms of the agreement, Crdentia will be drawing on its expansive database of healthcare professionals to provide registered nurses (RNs) and licensed practical nurses (LPNs) to staff their onsite facility for private non-pro events.

John Kaiser, Crdentia's CEO, commented, "I am very pleased that Crdentia has been awarded this contract. Our commitment to providing high quality healthcare staff of all specialties differentiates us from other major providers and was a key factor in Crdentia being selected to provide staffing services for High Rock Raceway. We believe that this relationship will lead to additional contracts with facilities of this nature across the country."

About Crdentia Corp.

Crdentia Corp., one of the nation's leading providers of healthcare staffing solutions, is focused on recruiting talented national and international healthcare professionals to meet the ever-increasing employment needs of over 1,500 clients. Crdentia is one of the few companies that can provide quality temporary staff for all healthcare industry positions including local nurses, travel nurses, allied health and locum tenens professionals. For more information, visit http://www.crdentia.com.

Forward Looking Statements

Statements contained i
'/>"/>

SOURCE Crdentia Corp.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Hospital Selected to ‘25 Most Influential’ List in Radiology in 206
2. Six Towns in India Selected for Eco-City Project
3. Acupuncture provides relief
4. Micro-camera provides new breast imaging technique
5. MicroRNA provides new insight into birth defects
6. Reliance Infocomm Tied With Apollo To Provide Telemedicine Services
7. Hormone therapy provides no heart benefit
8. Clothes may provide better protection against sun-related skin problems in children
9. Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients
10. Neurobiology Provides Answers To Block Memory-Related Drug Cravings
11. Leeches Provide Clues Regarding The Prevention Of Heart Disease

Post Your Comments:

(Date:11/26/2009)...is & Ennis, P.A. is offering free nationwide c...min birth control pills who have suffered a Deep V...Heart Attack or other related cardiac issues or ha...ree at 1-800-856-6405 or go to the firm’s we... online case evaluation form. , ...

(Date:11/25/2009)...wire/-SentinelleMedicalInc.,aleadingmanufacturerof...chesasuiteofnewleadingedgeclinicalapplicationsonit...,sRadiologicalSocietyofNorthAmerica(RSNA)annualmee...heapplicationsleveragetheuniquehighqualityimagesge...supportmultipleimagingmodalitiesformulti-parametri...

(Date:11/25/2009)...ements,Business,andPressJoinEfforttoEducate ,,...again,theNationalBipolarFoundationandtheMedicAlert...tilStable"program,whichisnowbeingwidelyacceptedasa...y,theNationalBipolarFoundationreceivedaproclamatio...Lt.GovernorofLouisianaMitchLandrieu.TheNationalBip...

(Date:11/25/2009)...s too short to draw definite conclusions, experts ...News) -- In diabetic patients with blocked coronar...utcomes at one year whether patients undergo bypas...searchers report. , Bypass surgery has been the...onary artery disease. However, less invasive appro...

(Date:11/25/2009)...es few signs of trouble with the H1N1 vaccine, ,... The ongoing H1N1 swine flu pandemic may be drivin...nger patients, a U.S. health official said Wednesd...umococcal infections around the country," Dr. Anne...unization and Respiratory Diseases at the U.S. Cen...

Breaking Medicine News(10 mins):Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2 Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3 Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2 Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3 Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2 Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3 Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2 Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3 Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2 Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3 Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4

[0] Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills [1] Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology [0] First Time-Door is Open for Family Discussion of Bipolar Disorder [1] Stenting May Equal Bypass for Diabetic Heart Patients [0] Swine Flu Tied to Rise in Pneumonias Among Young

...ion, Training and Resources, WASHINGTON, Dec. 6 ...unced it will provide nearly $4.7 million,for "car...prove health care,education and provide needed tra...mily members,and other caregivers who sacrifice to...

...hua-PRNewswire-FirstCall/ -- China Shenghuo,Pharma...mpany") (Amex:,KUN), which is engaged in the resea...armaceutical, nutritional supplement and cosmetic ...s,12Ways(R) Chinese Herbal Cosmetics on China Cent...

...y might prevent cardiac arrest , , THURSDA...,re moving closer to using transplanted cells to p...n cardiac arrest. , Working with mice, scientists...-author Dr. Michael Kotlikoff, a professor in the ...

... First Half of 2008 -, SAN DIEGO and INDIANAPOLIS...MLN ) and Eli Lilly and Company (NYSE: LLY ),toda...monotherapy, or,stand-alone, BYETTA (exenatide) in...wed significant reductions in A1C (a,measure of av...

...oducts to Reach Sales of $1 Billion or More in ...ipeline Offers Promising Outlook; 6 Launches Expec... - R&D Investment and Productivity Gains plus Aggr...t Outcomes,- Lilly Reconfirms 2007 Sales and Earni...

...y, the nation,s leading,oncology services company,...xecutive vice president and chief operating office... 2008., "Glen,s Fortune 500 operating experience,...nt of US Oncology.,"His proven success in working ...

VA Announces $4.7 Million to Help Caregivers China Shenghuo Pharmaceutical Holdings, Inc. to Launch 12Ways(R) Advertisement on CCTV in January 2008 Cell Transplants Hold Promise for Heart Attack Survivors Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy US Oncology Appoints Glen Laschober EVP & Chief Operating Officer

(Date:11/25/2009)...FirstCall/--Abaxis,Inc.(Nasdaq: ABAX ),amedicalpro...ssystems,announcedtodaythatClintSeverson,chairmana...PiperJaffrayHealthCareConferenceonWednesday,Decemb...ewYorkPalaceHotelinNewYorkCity. ,, AboutAbaxis...blebloodanalysissystemsforuseinanyveterinaryorhuma...

(Date:11/25/2009)...-CempraPharmaceuticalsInc.todayannouncedthatPrabha...illpresentatthePiperJaffray21stAnnualHealthCareCon...laceHotelinNewYorkCity.Dr.Fernandeswillprovideanov...ogramsforthetreatmentofdrug-resistantpathogensincl..., Foundedin2006,CempraPharmaceuticalsisaprivately-...

(Date:11/25/2009)...Newswire-FirstCall/--HeartWareInternational,Inc.(N...oflessinvasive,miniaturizedcirculatorysupporttechn...ailure,todayannouncedthatitisscheduledtomakeaninve...areConferenceat8:00amESTonWednesday,December2,2009...ecember1-2. ,, AlivewebcastoftheCompany,spresen...

Breaking Medicine Technology:Vion Pharmaceuticals Announces Results of the Oncologic Drugs Advisory Committee Meeting for Onrigin 28TM 29 4936 1 Vion Pharmaceuticals Announces Results of the Oncologic Drugs Advisory Committee Meeting for Onrigin 28TM 29 4936 2 Vion Pharmaceuticals Announces Results of the Oncologic Drugs Advisory Committee Meeting for Onrigin 28TM 29 4936 3 New Technique Offers Hope for Kids With Immune Deficiency 55986 1 New Technique Offers Hope for Kids With Immune Deficiency 55986 2 PTC Therapeutics Announces Celgene Exercised Option to Drug Discovery Collaboration 13793 1 PTC Therapeutics Announces Celgene Exercised Option to Drug Discovery Collaboration 13793 2

[0] Abaxis, Inc. to Present at the 21st Annual Piper Jaffray Health Care Conference [0] Cempra Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference [0] HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City

...t Lymphoma Meeting in Lugano, Switzerland, SOUTH ...d an abstract providing preliminary results of a P...788 (fostamatinib disodium), in,patients with rela...(NHL).,The abstract reports favorable responses fo...ma/chronic lymphocytic leukemia (SLL/CLL) or from ...

...f., June 2 Rigel,Pharmaceuticals, Inc. (Nasdaq: ...nce call with simultaneous webcast to discuss the ...of R788, a novel, oral Syk kinase,inhibitor, in pa...day, June,3, 2008 at 8:00 a.m. EDT. Participating ...e principal investigator on the study, Jonathan Fr...

Other Medicine Technology:Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL 2 Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL 3 Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL 4 Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma 2

Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma

...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...

Medicine Products:

Xylocaine Wilson Disease Screening Test Wilson Disease Screening Panel, Serum Western Equine Encephalitis Antibody, IgG by IFA, Serum

Crdentia Selected by High Rock Raceway to Provide Healthcare Staffin...( DALLAS Sept. 6 /- Crdentia Corp. ...),Health